Background Aspirin-induced asthma (AIA) affects one in 10 individuals with adult-onset asthma. It is not known if aspirin sensitivity is due to immune mechanisms or to interference with biochemical pathways.

Objective The study aimed to test for possible involvement of the genes of the Major Histocompatibility Complex (MHC) in AIA.

Methods HLA-DPB1 and HLA-DRB1 genotyping was carried out by DNA methods in 59 patients with positive challenge tests for AIA and in 48 normal and 57 asthmatic controls

Results The DPB 1*0301 frequency was increased in AIA patients when compared with normal controls (19.5% vs 5.2%, Odds Ratio = 4.4, 95% Confidence Interval (CI) 1.6–12.1, P= 0.002), and compared with asthmatic controls (4.4%, OR = 5.3, 95%CI= 1.9–14.4, P= 0.0001). The frequency of DPB 1*0401 in AIA subjects was decreased when compared with normal controls (28.8% vs 49.0%, OR = 0.42, 95%CI = 0.24–0.74, P= 0.003) and asthmatic controls (45.6%, OR = 0.48, 95%CI = 0.28–0.83, P= 0.008). The results remained significant when corrected for multiple comparisons. There were no significant HLA-DRB 1 associations with AIA.

Conclusion The presence of an HLA association suggests that immune recognition of an unknown antigen may be part of the aetiology of AIA.

References

1 Szezeklik A. Aspirin-Induced Asthma. In: JR Vane, RM Botting, eds. Aspirin and other salicylates. London , Chapman and Hall 1992: 548–75.
Google Scholar
2 Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary Leukotriene-E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143: 1025–9.
10.1164/ajrccm/143.5_Pt_1.1025
PubMed Web of Science® Google Scholar
3 Picado C, Ramis I, Rosello J et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992; 145: 65–9.
10.1164/ajrccm/145.1.65
PubMed Web of Science® Google Scholar
4 Sladek K, Dworski R, Soja J et al. Eicosanoids in bronchoalveolar fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 149: 940–6.
10.1164/ajrccm.149.4.8143059
PubMed Web of Science® Google Scholar
5 Israel E, Fischer AR, Rosenberg MA et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993; 148: 1447–51.
10.1164/ajrccm/148.6_Pt_1.1447
CAS PubMed Google Scholar
6 Kumlin M, Dahlen B, Bjorck T et al. Urinary excretion of Leukotriene E4 and 11-dehydro-Thromboxane B2 in response to Bronchial provocations with allergen, Aspirin, Leukotriene D4 and histamine in asthmatics. Am Rev Respir Dis 1992; 146: 96–103.
10.1164/ajrccm/146.1.96
PubMed Web of Science® Google Scholar
7 Drazen JM, O'Brien J, Sparrow D et al. Recovery of Leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992; 146: 104–6.
10.1164/ajrccm/146.1.104
CAS PubMed Web of Science® Google Scholar
8 Ameisen JC, Capron A. Aspirin-sensitive asthma. Clin Exp Allergy 1990; 20: 127–30.
10.1111/j.1365-2222.1990.tb02656.x
CAS PubMed Web of Science® Google Scholar
9 Mullarkey MF, Thomas PS, Hansen JA et al. Association of aspirin-sensitive asthma with HLA-DQw2. Am Rev Respir Dis 1986; 133: 261–63.
PubMed Web of Science® Google Scholar
10 Schmitz-Schumann M, Menz, G, Virchow C et al. The HLA system and analgesic-induced asthma syndrome. Pneumologie 1990; 44 Suppl 1; 580–1.
PubMed Google Scholar
11 Krishnamoorthy R. HLA class II haplotypes in aspirin-induced asthma. The genetics of asthma. Eds DG Marsh, A Lockhart ST Holgate, Blackwell Scientific Publications, 1993: 225–34.
Web of Science® Google Scholar
12 Lympany PA, Welsh KI, Christie PE et al. An analysis with sequence-specific oligonucleotide probes of the association between aspirin-induced asthma and antigens of the HLA system. J Allergy Clin Immunol 1993; 92: 114–23.
10.1016/0091-6749(93)90045-H
PubMed Web of Science® Google Scholar
13 Szezeklik A, Nizankowska E. Pharmacological agents in bronchial provocation tests. In L Allegra, P Braga, R Dal Negro, eds. Methods in asthmology. Raven Press, New York , 1990.
Google Scholar
14 Szezeklik A, Nizankowska E. Asthme bronchique et medicaments anti-inflammatoires non-steroidiens. In J Charpin, D Vervolet, eds. Allergologie. Flammarion, Paris 1992.
Google Scholar
15 Schmitz-Schumann M, Juhl E, Costabel E et al. Analgetika provokationsproben bei Analgetika-Asthma-Syndrom. Atemwegs Lungenkrakhl 1985; 1: 479–86.
Google Scholar
16 Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1990. Tissue Antigens 1991; 37: 97–104.
10.1111/j.1399-0039.1991.tb01853.x
CAS PubMed Web of Science® Google Scholar
17 Dekker JW and Easteal E: HLA-DP typing by amplified fragment length polymorphisms (AFLPs). Immunogenetics 1990; 32: 56–9.
10.1007/BF01787330
CAS PubMed Web of Science® Google Scholar
18 Wordsworth BP, Allsop CEM, Young RP et al. HLA-DR typing using DNA amplification by polymerase chain reaction and sequential hybridisation to sequence specific oligonucleotide probes. Immunogenetics 1990; 32: 413–8.
10.1007/BF00241635
CAS PubMed Web of Science® Google Scholar
19 Young RP, Dekker JW, Wordsworth BP et al. HLA-DR and HLA-DP genotypes and Immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994; 24: 431–9.
10.1111/j.1365-2222.1994.tb00931.x
CAS PubMed Web of Science® Google Scholar
20 Richeldi L, Sorrentino R and Saltini C. HLA-DPB1 Glutamate 69: A genetic marker of Beryllium Disease. Science 1993; 262: 242–4.
10.1126/science.8105536
CAS PubMed Web of Science® Google Scholar
21 Bignon JS, Aron Y, Ju LY et al. Class II alleles in isocyanate- induced asthma. Am J Resp Crit Care Med 1994; 149: 71–5.
10.1164/ajrccm.149.1.8111601
PubMed Web of Science® Google Scholar
22 Young RP, Barker RD, Pile KD et al. The association of HLA- DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med 1995; 151: 219–21.
10.1164/ajrccm.151.1.7812558
PubMed Web of Science® Google Scholar
23 Fernandez-Vina M, Fink CW, Stastny P. HLA associations in juvenile arthritis. Clin Exp Rhematol 1994; 12: 205–14.
PubMed Web of Science® Google Scholar
24 Szezeklik A. Aspirin-induced Asthma as a viral disease. Clinical Allergy 1988; 18: 15–20.
10.1111/j.1365-2222.1988.tb02838.x
PubMed Web of Science® Google Scholar
25 Szezeklik A, Schmitz-Schumann M, Nizankowska E et al. Altered distribution of IgG subclasses in aspirin-induced asthma: high IgG4, low IgGl. Clin Exp Allergy 1992; 22: 283–7.
10.1111/j.1365-2222.1992.tb03084.x
PubMed Web of Science® Google Scholar
26 Szezeklik A, Nizankowska E, Serafin A et al. Autoimmune phenomena in bronchial asthma, with special reference to aspirin intolerance. Am J Respir Crit Care Med 1995; 152: 1753–6.
10.1164/ajrccm.152.6.8520733
PubMed Web of Science® Google Scholar

Citing Literature

Volume27, Issue5

May 1997

Pages 574-577

Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes

Summary

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes

Summary

References

Citing Literature

References

Related

Information